D.C. bill would regulate pharma reps, use of Rx data

A bill to regulate pharmaceutical sales representatives was approved 7-6 on first reading by the District of Columbia Council on Dec. 11.
The bill, said to be the first of its kind, would require the licensing of those sales reps, prohibit using physicians’ private prescription data for marketing purposes without their consent, and create a program for educating doctors on the latest drug research as a way of countering biased marketing-driven information they receive from sales representatives.

Leave a Reply

Your email address will not be published. Required fields are marked *